FDA steps up scrutiny of regenerative medicine

(Reuters) - The U.S. Food and Drug Administration (FDA) is stepping up efforts to better regulate an emerging field of medicine that holds significant promise for curing some of humanity's most troubling maladies by using the body's own cells.